Short Interest in PureTech Health plc (OTCMKTS:PTCHF) Declines By 29.1%

PureTech Health plc (OTCMKTS:PTCHF) saw a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 48,500 shares, a decline of 29.1% from the March 31st total of 68,400 shares. Based on an average trading volume of 6,600 shares, the short-interest ratio is presently 7.3 days.

PureTech Health Price Performance

OTCMKTS PTCHF remained flat at $2.70 on Monday. The firm has a 50 day moving average of $2.64 and a 200 day moving average of $2.34. PureTech Health has a 1-year low of $1.69 and a 1-year high of $3.10.

About PureTech Health

PureTech Health plc, a clinical stage biotherapeutics company, engages in the discovery, development, and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, currently under Phase 3 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, to inhibit the activity of galectin-9 for treating solid tumors and hematological malignancies.